Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy

NCT00000807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Etoposide

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]